A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer
Titel:
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer
Auteur:
Spetsieris, Nicholas Boukovala, Myrto Weldon, Justin A. Tsikkinis, Alexandros Hoang, Anh Aparicio, Ana Tu, Shi-Ming Araujo, John C. Zurita, Amado J. Corn, Paul G. Pagliaro, Lance Kim, Jeri Wang, Jennifer Subudhi, Sumit K. Tannir, Nizar M. Logothetis, Christopher J. Troncoso, Patricia Wang, Xuemei Wen, Sijin Efstathiou, Eleni